COMPANY

Inflammasome Therapeutics

Inflammasome Therapeutics is a science based company founded to develop therapies for degenerative diseases such as Alzheimer's disease, multiple sclerosis, macular degeneration, and Parkinson's disease. From company website Source · checked 2026-10-19

Sources for this description (1)

Inflammasome Therapeutics is a science based company founded to develop therapies for degenerative diseases such as Alzheimer's disease, multiple sclerosis, macular degeneration, and Parkinson's disease.
- “Inflammasome Therapeutics is a science based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer's disease, multiple sclerosis, macular degeneration, and Parkinson's disease.” https://inflam.com/about/about-inflammasome (2026-10-19)

Keywords: neurology Alzheimer's disease multiple sclerosis macular degeneration sustained release

Location: Newton, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $13.16M (Form D filed May 4, 2026). SEC Form D 0001989925-26-000003 (May 4, 2026)
Evidence (1 event)
- May 4, 2026 · SEC Form D 0001989925-26-000003
  Name of Issuer: Inflammasome Therapeutics, Inc.; CIK: 1989925; Address: Newton, MA; Submission type: D; Filing date: 2026-05-04; Industry Group: Biotechnology; Date of First Sale: 2026-02-27; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 13155645; Total Amount Sold: 13155645; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals